Aurobindo gets US FDA nod

In a chat with ET Now, AshwaniGujral, Fund Manager, ashwanigujral.com, shares his views on AurobindoPharma Ltd. ET Now: What is your call on ? Ashwani Gujral: is a 'BUY' call with a target of Rs 206 and a stop loss of

One can buy Aurobindo Pharma. There will be more upside in it, says Sudarshan Sukhani of s2analytics.com.

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Aurobindo Pharma is currently trading at Rs. 198.00, up by 1.45 points or 0.74% from its previous closing of Rs. 196.55 on the BSE. The scrip opened at Rs. 198.50 and has touched a high and low of Rs. 199.25 and Rs. 197.80 respectively. So far ...

This is a work on the entire creative literature of Sri Aurobindo comprising of his poetry, dramas and short stories. There are number of books on his creative literature besides philosophy, essays and other areas of his life and work but it is ...

Auto stocks like Tata Motor, Maruti Suzuki, Bajaj Auto and pharma stocks like Cipla, Dr Reddys, Aurobindo Pharma will be getting astrological support says Satish Gupta of Astrostocktips.

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani of AMSEC Research shares his trading strategies for the day.

The otherwise spick and span Sri Aurobindo Ashram bore a war-ravaged look after it was ransacked by activists of a Tamil outfit on Thursday afternoon. However, barely two hours after the attack, all the tell-tale signs vanished. There were no broken ...

In CNBC-TV18's popular show Bull's Eye, Lancelot D Cunha, ITI Wealth Management shares trading strategy of the day.